학술논문

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
Document Type
Journal
Source
HUMAN VACCINES & IMMUNOTHERAPEUTICS; AUG 1 2023, 19 2, p2233400 12p.
Subject
Language
English
ISSN
2164554X